NR1I2 and gastrointestinal stromal tumor: Determination of unbound drug concentration and genotyping of SLC22A1 (rs755828176) and NR1I2 (rs3814055) genes may be considered in patients with GIST to individualize the therapy and optimize the clinical outcomes.